DuPont de Nemours (DD)
(Delayed Data from NYSE)
$87.54 USD
+0.40 (0.46%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $87.52 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$87.54 USD
+0.40 (0.46%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $87.52 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
Zacks News
International Flavors (IFF) Updates 2021 Sales & EBITDA Guidance
by Zacks Equity Research
International Flavors (IFF) expects sales growth higher than 8% in 2021 and adjusted operating EBITDA margin to be approximately 21.5%.
4 Diversified Chemical Stocks to Watch Out for Amid Industry Woes
by Anindya Barman
Raw material cost pressure and demand worries due to chip shortage and the spread of the Delta variant pose as headwinds for the Zacks Chemicals Diversified industry. DOW, OLN, CC and AVNT are poised to survive the industry challenges.
Why Is DuPont de Nemours (DD) Down 1.1% Since Last Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
International Flavors (IFF) to Divest Microbial Control Business
by Zacks Equity Research
International Flavors' (IFF) latest deal enables it to focus on core business operations by strengthening the balance sheet, while maximizing shareholder returns.
International Flavors (IFF) Q2 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q2 top-line results reflect benefits from solid growth in Scent and Nourish as well as additional sales related to the merger with DuPont's Nutrition & Biosciences (N&B) business.
DuPont (DD) Tops Q2 Earnings & Sales Estimates, Raises FY21 View
by Zacks Equity Research
DuPont (DD) gains on a recovery in key end-markets such as automotive, construction and industrial and sustained strength in semiconductor and smartphones in Q2.
DuPont de Nemours (DD) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 12.77% and 3.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Why DuPont (DD) Might Surprise This Earnings Season
by Zacks Equity Research
DuPont (DD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Albemarle (ALB) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher volumes and prices in its lithium business in the second quarter.
Chemical Stock Q2 Earnings Due on Aug 3: DD, FMC, WLK & KWR
by Anindya Barman
Strong end-market demand and the benefits of strategic measures are likely to have aided the performance of chemical companies in Q2. Let's see how DD, FMC, WLK and KWR are poised ahead of their earnings releases.
3 Chemical Stocks Likely to Outshine Q2 Earnings Estimates
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to reflect on the Q2 performance of Westlake (WLK), DuPont (DD) and Eastman Chemical (EMN).
DuPont (DD) Warms Up to Q2 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from its cost and productivity actions and higher demand in Q2 amid headwinds from higher raw material costs.
DuPont de Nemours (DD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
DuPont de Nemours (DD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Materials ETFs Set to Gain As Q2 Earnings Unfold
by Sweta Killa
With earnings surprises in the cards for many companies, materials ETFs might see smooth trading in the weeks ahead.
Will DuPont de Nemours (DD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks Market Edge Highlights: DuPont, Nutrien, Transcat, Heritage Crystal Clean and Boot Barn
by Zacks Equity Research
Zacks Market Edge Highlights: DuPont, Nutrien, Transcat, Heritage Crystal Clean and Boot Barn
How to Use the Zacks Rank to Find Hidden Gem Stocks
by Tracey Ryniec
Look beyond FAANG to find unknown companies with the possibility of tremendous growth and value.
DuPont (DD) Wraps Up Laird Performance Materials Buyout
by Zacks Equity Research
DuPont (DD) along with Laird Performance Materials is expected to leverage its extensive customer base and global scale to accelerate speed to market.
Top Ranked Income Stocks to Buy for June 30th
by Zacks Equity Research
IPG, NEXA, FBIZ, and DD made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 30, 2021
U.S. Chemical Volumes Set for An Upswing in 2021: 5 Picks
by Anindya Barman
The U.S. chemical industry is poised for an upturn this year on strength across major end-markets, higher industrial activities and a recovery in chemical exports. UNVR, CBT, DD, OLN and DOW are worth a wager right now.
After Plunging 8.8% in 4 Weeks, Here's Why the Trend Might Reverse for DuPont de Nemours (DD)
by Zacks Equity Research
The heavy selling pressure might have exhausted for DuPont de Nemours (DD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
4 Stocks to Watch in the Growing Nanotechnology Market
by Kaustav Ghosh
Watch out for names like Onto Innovation (ONTO), DuPont de Nemours (DD), Thermo Fisher Scientific (TMO) and International Business Machines (IBM) as the nanotechnology market continues to grow.
Why Is DuPont de Nemours (DD) Up 4.6% Since Last Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Earnings Estimates Rising for DuPont de Nemours (DD): Will It Gain?
by Zacks Equity Research
DuPont de Nemours (DD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why You Should Add DuPont (DD) to Your Portfolio
by Zacks Equity Research
DuPont (DD) gains from strong demand, cost actions and innovation-driven investment.